Key Symptom Domains to Be Assessed in Fibromyalgia (Outcome Measures in Rheumatoid Arthritis Clinical Trials)

被引：27
|
作者：
Choy, Ernest H. [1 ]
Mease, Philip J. [2 ,3 ]
机构：
[1] Kings Coll London, Weston Educ Ctr, Acad Dept Rheumatol, Sir Alfred Baring Garrod Clin Trials Unit, London SE5 9RJ, England
[2] Swedish Med Ctr, Div Rheumatol Res, Seattle, WA 98104 USA
[3] Univ Washington, Seattle, WA 98104 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2009年 / 35卷 / 02期
关键词：
Fibromyalgia; Domains; Core data set; Assessment; Clinical trials; PAIN; PREVALENCE; DIAGNOSIS; CRITERIA; IMPACT;
D O I：
10.1016/j.rdc.2009.05.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article discusses the key symptom domains to be assessed in fibromyalgia. Development of a consensus on a core set of outcome measures that should be assessed and reported in all clinical trials is needed to facilitate interpretation, pooling, and comparison of results. This aligns with the key objective of the Outcome Measures in Rheumatoid Arthritis Clinical Trials initiative to improve outcome measurement in rheumatic diseases through a data-driven interactive consensus process.
引用
下载
收藏
页码：329 / +
页数：10
相关论文
共 50 条
  • [41] WHICH OUTCOME MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CLINICAL AND QUALITY-OF-LIFE MEASURES RESPONSIVENESS TO TREATMENT IN A RANDOMIZED CONTROLLED TRIAL
    BUCHBINDER, R
    BOMBARDIER, C
    YEUNG, M
    TUGWELL, P
    ARTHRITIS AND RHEUMATISM, 1995, 38 (11): : 1568 - 1580
  • [42] Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials
    Ward, Michael M.
    Guthrie, Lori C.
    RHEUMATOLOGY, 2017, 56 (02) : 239 - 246
  • [43] WHICH TRADITIONAL MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    ANDERSON, JJ
    FELSON, DT
    MEENAN, RF
    WILLIAMS, HJ
    ARTHRITIS AND RHEUMATISM, 1989, 32 (09): : 1093 - 1099
  • [44] INTERNATIONAL CONSENSUS ON WHICH MEASURES TO USE IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    BOERS, M
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 43 (1-2): : 55 - 58
  • [45] THE IMPACT OF END-POINT MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    VANDERHEIDE, A
    JACOBS, JWG
    DINANT, HJ
    BIJLSMA, JWJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) : 287 - 294
  • [46] COMPARISON OF SUBJECTIVE AND OBJECTIVE MEASURES OF SLEEP IN PATIENTS WITH FIBROMYALGIA AND RHEUMATOID ARTHRITIS
    Storrs, Penny J.
    Brockley, Cai
    McKenna, Frank
    RHEUMATOLOGY, 2009, 48 : I136 - I136
  • [47] Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience
    Salaffi, F.
    Ciapetti, A.
    Puttini, P. Sarzi
    Atzeni, F.
    Iannuccelli, C.
    Di Franco, M.
    Cazzola, M.
    Bazzichi, L.
    REUMATISMO, 2012, 64 (01) : 27 - 34
  • [48] MEASURING OUTCOME IN RHEUMATOID-ARTHRITIS - WHICH MEASURES ARE SUITABLE FOR ROUTINE CLINICAL USE
    SYMMONS, DPM
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (09): : 802 - 804
  • [49] THE SEARCH FOR LABORATORY MEASURES OF OUTCOME IN RHEUMATOID-ARTHRITIS
    WOLLHEIM, FA
    EBERHARDT, KB
    BAILLIERES CLINICAL RHEUMATOLOGY, 1992, 6 (01): : 69 - 93
  • [50] The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis - Relative validity of scales in relation to clinical measures of arthritis severity
    Kosinski, M
    Keller, SD
    Ware, JE
    Hatoum, HT
    Kong, SXD
    MEDICAL CARE, 1999, 37 (05) : MS23 - MS39
12345